Combination therapy with anti-HIV-1 antibodies maintains viral suppression-Reference-Cited by-同舟云学术

Combination therapy with anti-HIV-1 antibodies maintains viral suppression

Published:2018-09 Issue:7724 Volume:561 Page:479-484
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Mendoza Pilar,Gruell Henning,Nogueira Lilian,Pai Joy A.,Butler Allison L.,Millard Katrina,Lehmann Clara,Suárez Isabelle,Oliveira Thiago Y.,Lorenzi Julio C. C.,Cohen Yehuda Z.,Wyen Christoph,Kümmerle Tim,Karagounis Theodora,Lu Ching-Lan,Handl Lisa,Unson-O’Brien Cecilia,Patel Roshni,Ruping Carola,Schlotz Maike,Witmer-Pack Maggi,Shimeliovich Irina,Kremer Gisela,Thomas Eleonore,Seaton Kelly E.,Horowitz Jill,West Anthony P.,Bjorkman Pamela J.,Tomaras Georgia D.,Gulick Roy M.,Pfeifer Nico,Fätkenheuer Gerd,Seaman Michael S.,Klein Florian,Caskey Marina,Nussenzweig Michel C.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-018-0531-2.pdf

Reference50 articles.

1. Doitsh, G. & Greene, W. C. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe 19, 280–291 (2016).

2. Churchill, M. J., Deeks, S. G., Margolis, D. M., Siliciano, R. F. & Swanstrom, R. HIV reservoirs: what, where and how to target them. Nat. Rev. Microbiol. 14, 55–60 (2016).

3. Nishimura, Y. et al. Early antibody therapy can induce long-lasting immunity to SHIV. Nature 543, 559–563 (2017).

4. Gautam, R. et al. A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection. Nat. Med. 24, 610–616 (2018).

5. Schoofs, T. et al. HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1. Science 352, 997–1001 (2016).

Cited by 404 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Vaccine Development at a Crossroads: New B and T Cell Approaches;Vaccines;2024-09-12

2. The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity;Journal of Virology;2024-09-09

3. Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention;Nature Immunology;2024-08-28

4. Impact of antiretroviral therapy during primary HIV infection on T‐cell immunity after treatment interruption;European Journal of Immunology;2024-08-13

5. Afucosylated broadly neutralizing antibodies enhance clearance of HIV-1 infected cells through cell-mediated killing;Communications Biology;2024-08-09